The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALNYLAM PHARMACEUTICALS INC COM 02043Q107 1,366 17,000 SH   DFND   17,000 0 0
AMERCO COM 023586100 15,827 40,224 SH   DFND   40,224 0 0
CAPITAL SOUTHWEST CORP COM 140501107 24,133 509,137 SH   DFND   509,137 0 0
LAKELAND INDS INC COM 511795106 3,518 253,300 SH   DFND   253,300 0 0
MMA CAP MGMT LLC COM 55315D105 424 32,466 SH   DFND   32,466 0 0
NATHANS FAMOUS INC NEW COM 632347100 4,860 127,820 SH   DFND   127,820 0 0
SYNERGETICS USA INC COM 87160G107 5,479 833,883 SH   DFND   833,883 0 0
TETRAPHASE PHARMACEUTICALS I COM 88165N105 90 12,000 SH   DFND   12,000 0 0
UNWIRED PLANET INC NEW COM 91531F103 1,434 1,978,525 SH   DFND   1,978,525 0 0
WINTHROP RLTY TR SH BEN INT NEW 976391300 10,459 728,321 SH   DFND   728,321 0 0
TARO PHARMACEUTICAL INDS LTD SHS M8737E108 108,585 759,920 SH   DFND   759,920 0 0